Medigene AG: Promising data from Phase I/II IIT and Compassionate Use Programme with dendritic cell vaccines in AML presented at ASH Annual Meeting 2015
Early results from an ongoing Phase I/II IIT and a Compassionate Use Programme presented on two posters by academic part…